Nutritional issues in anti-cancer treatment

Annals of Oncology

Volumn 19, Issue SUPPL. 5, 2008, Pages

  Vandebroek, A J V ^a   Schrijvers, D ^a  

^a ZiekenhuisNetwerk Antwerpen   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASCORBIC ACID; CETUXIMAB; CISPLATIN; CYANOCOBALAMIN; DACTINOMYCIN; DAUNORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLIC ACID; GINSENG EXTRACT; GREEN TEA EXTRACT; HYDROXYUREA; IRINOTECAN; MAGNESIUM; MELATONIN; METHOTREXATE; PACLITAXEL; PEMETREXED; PREDNISOLONE; SALVIA MILTIORRHIZA EXTRACT; TENIPOSIDE; TIOGUANINE; TRACE ELEMENT; UNINDEXED DRUG; VINCA ALKALOID; VITAMIN; VITAMIN K GROUP; WARFARIN;

ALTERNATIVE MEDICINE; ANOREXIA; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER THERAPY; CARNITINE DEFICIENCY; CONFERENCE PAPER; DIARRHEA; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG EXCRETION; DRUG MECHANISM; ENTERIC FEEDING; FLATULENCE; FUNCTIONAL STATUS; GASTROINTESTINAL DISEASE; GASTROSTOMY; HORMONE ACTION; HUMAN; HYPOMAGNESEMIA; IMMUNOMODULATION; LACTOSE INTOLERANCE; MALABSORPTION; MALNUTRITION; MUCOSA INFLAMMATION; NAUSEA; NEOPLASM; NONHUMAN; NUTRITIONAL STATUS; PREVALENCE; PRIORITY JOURNAL; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; VOMITING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

HUMANS; MALNUTRITION; NEOPLASMS; NUTRITIONAL STATUS;

EID: 49049121108     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn311     Document Type: Conference Paper

References (16)

1. Isenring E, Cross G, Daniels L et al. Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. Supp Care Cancer 2006; 14: 1152-1156.
2. Kiyomoto D. Head and neck cancer patients treated with chemo-radiotherapy require individualized oncology nutrition. J Am Diet Assoc 2007; 107: 412-415.
3. Alexandre J, Gross-Goupil M, Falssard B et al. Evaluation of the nutritional and inflammatory status in cancer patients for the risk assesment of severe haematological toxicity following chemotherapy. Ann Oncol 2003; 14: 36-41.
4. Murry D, Riva L, Poplack D. Impact of nutrition on pharmacokinetics of antineoplastic agents. Int J Cancer 1998; S11: 48-51.
5. Alleyne GAO. The effect of severe protein caloric malnutrition on the renal function of Jamaican children. Pediatrics 1967: 39400-39411.
6. Österlund P, Ruotsalainen T, Peuhkuri K et al. Lactose intolerance associated with adjuvant 5-fluorouracil-based chemotherapy for colorectal cancer. Clin Gastroenterol Hepatol 2004; 2: 696-703.
7. Trier JS. Morphologic alterations induced by methotrexate in the mucosa of the human proximal intestine. Observations by light microscopy. Gastroenterology 1962; 43: 295-305.
8. Jackson MJ. Physiology of zinc: General aspect. In Millls CF (ed): Zinc in Human Biology. London: Springer, 1-14.
9. Federico A, Iodice P, Federico P et al. Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. Eur J Clin Nutrition 2001; 55: 293-297.
10. Schrag D, Chung KY, Flombaum C, Saltz L. Cetuximab therapy and symptomatic hypomagnesiemia. J Natl Cancer Inst 2005; 97: 1221-1224.
11. Heuberger W, Berardi S, Jacky E et al. Increased urinary excretion of carnitine in patients treated with cisplafin. Eur J Clin Pharmacol 1998; 54: 503-508.
12. Li KM, Rivory LP, Clarke SJ. Pemetrexed pharmacokinetics and pharmacodynamics in a phase 2 study of doublet chemotherapy with vinorelbine: Implications for further optimisation of pemetrexed schedules. Br J Cancer 2007; 97: 1071-1076.
13. Richardson MA, Sanders T, Palmer JL et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000; 18: 2505-2514.
14. Boullata J. Natural health product interactions with medication. Nutr Clin Pract 2005; 20: 33-51.
15. Michaud LB, Karpinski JP, Jones KL, Esperito J. Dietary supplements in patients with cancer: Risks and key concepts, part 1. Am J Health-syst Pharm 2007; 64: 369-381.
16. Michaud LB, Karpinski JP, Jones KL, Esperito J. Dietary supplements in patients with cancer: Risks and key concepts, part 2. Am J Health-syst Pharm 2007; 64: 467-480.